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INTERLEUKIN 2 ACTIVATION OF
NATURAL KILLER CELLS RAPIDLY INDUCES THE
EXPRESSION AND PHOSPHORYLATION OF
THE Leu-23 ACTIVATION ANTIGEN
By LEWIS L. LANIER, DAVID W. BUCK, LORI RHODES, ATHENA DING,
ELIZABETH EVANS, COLLEEN BARNEY, ANDJOSEPH H. PHILLIPS
From the Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043
IL-2 potentiates both growth and cytotoxic function of T lymphocytes and NK
cells. Resting peripheral blood NK cells can respond directly to rIL-2, without
requirement for accessory cells or cofactors, and enhanced cytotoxicity can be
measured within 4 h after exposure to this lymphokine (1-3) . The majority of
NK cells enter the cell cycle after exposure to IL-2 ; however, only a minor pro-
portion sustain continued growth after this initial response (4) . By contrast,
most resting peripheral blood T cells do not respond directly to IL-2, but
require additional signals (e .g ., IL-1 or activators of protein kinase C) to induce
proliferation (4-6). A subset of low buoyant density T cells, isolated by Percoll
gradient centrifugation, can respond directly to IL-2 (4), presumably since these
T cells are in a "primed" state and require only IL-2 for proliferation .
Activation and proliferation of T cells is accompanied by the de novo expres-
sion of new antigens on the plasma membrane (7-13) . With respect to NK cells,
activation by IL-2, or in mixed lymphocyte cultures, induces the expression of
transferrin receptors, HLA-DR and the CD25 IL-2-R (4, 14-16) . However,
whereas IL-2-induced augmentation of NK cell-mediated cytotoxicity can be
detected within 4 h and is maximal by 18 h after activation, HLA-DR and CD25
are not detectable on the majority of NK cells during this time period (2-4, 16).
Thus, there is no direct correlation between the expression of these activation
antigens and lytic activity . In this study, we describe an activation antigen, Leu-
23, that is rapidly induced and phosphorylated after IL-2 stimulation of NK cells
and a subset of low buoyant density T lymphocytes . Induction of this glycopro-
tein on NK cells is IL-2 dependent and closely parallels the acquisition of lytic
activity .
Materials and Methods
Cells. Mononuclear cells from normal peripheral blood (Stanford Blood Center,
Stanford, CA) were isolated using Ficoll/Hypaque . After plastic adherence and passage
through nylon wool to remove monocytes and B cells, respectively, lymphocytes were
fractionated by centrifugation on discontinuous gradients consisting of 30 and 40% Per-
coll (Pharmacia Fine Chemicals, Piscataway, NJ) in PBS (0.01 M phosphate, 150 mM
NaCI, pH 7.3) containing 10% serum (17) . Low buoyant density and high buoyant den-
sity lymphocytes were isolated from the interface and bottom of the Percoll gradients,
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respectively . Normal thymocytes were obtained from children undergoing cardiac
surgery.
Culture. Lymphocytes and thymocytes were cultured in RPMI 1640 medium (M.A .
Bioproducts, Walkersville, MD) containing 1 mM glutamine (Gibco Laboratories, Grand
Island, NY), 100 Ag/ml gentamicin (Gibco Laboratories) and either FCS (KC Biological,
Inc ., Lenex, KS) or heat-inactivated horse serum (KC Biological, Inc.) . Lymphocytes were
activated and cultured using rIL-2 (Cetus Corp., Emeryville, CA). In experiments to
establish conditions necessary for the induction of activation antigens, serum-free HB101
medium (Hana Biologicals, Alameda, CA) was used to exclude potential nonspecific stim-
ulation by heterologous serum.
Antibodies. Leu series mAbs were produced by the Becton Dickinson Monoclonal
Center, Inc., Mountain View, CA . Anti-Leu-23 is an IgGI mAB secreted by the L78
hybridoma cell line . L78 hybridoma was generated by immunizing BALB/c mice with a
CD8 + alloantigen-directed CTL cell line . Immune lymph node cells were fused with SP2/
0 Ag14 myeloma cells, and hybridomas were selected in azaserine (18) . Rabbit anti-IL-2
serum was purchased from Genzyme, Boston, MA. Goat anti-IL-2 serum (16) was gen-
erously provided by Dr. Giorgio Trinchieri, Wistar Institute, Philadelphia, PA .
Immunofluorescence and Flow Cytometry. Methods of immunofluorescence, flow cytom-
etry, and data analysis have been described previously (19) . Fluorescence was measured
by usinga FACS 440 and data were analyzed by using a Consort 40 Data Analysis System
(Becton Dickinson Immunocytometry Systems) .
Cytotoxic Assay. "'Cr-labeled tumor cells were used as targets in a 4-h radioisotope
release assay (20) .
Immunoprecipitation and Electrophoresis . Cells were labeled with '25I (Amersham Corp .
Airlington Heights, IL) by using the glucose oxidase/lactoperoxidase method (21) . Cells
were solubilized in lysis buffer (50 mM Tris-HCI, 150 mM NaCl, 0.02% sodium azide,
pH 8.0) containing 5 mM 3[3-cholamidopropyl-dimethylammonio]-1-propane sulfonate
(CHAPS)' detergent, 20 KI U/ml aprotinin (Sigma Chemical Co., St . Louis, MO) and 1
mM PMSF (Sigma Chemical Co.) . Unincorporated ' 25 1 was removed using Dowex 1X8-
400 ion exchange resin (Sigma Chemical Co.), and lysates were precleared by incubation
with formalin-fixed Staphylococcus aureus (Pansorbin ; Calbiochem-Behring Corp., San
Diego, CA) coated with rabbit anti-mouse Ig serum (Pel-Freeze Biologicals, Rogers,*AR)
(22) . Immunoprecipitation was performed using rabbit anti-mouse Ig-coated S. aureus,
as described (22) . Samples were analyzed by SDS-PAGE (23), two-dimensional "diagonal"
(1st dimension nonreducing; 2nd dimension, reducing) (24), and two-dimensional non-
equilibrium pH gradient electrophoresis (NEPHGE) using 3.5-10% ampholines (LKB
Instruments, Inc., Gaithersburg, MD) (25) .
Deglycosylation. Antigen was eluted by adding 20 A1 of phosphate buffer (0 .1 M, pH
6.1) containing 50 mM EDTA, 1% 2-ME, and I% SDS to the S. aureus/immune complex.
After incubation at 56°C for 20 min, the S. aureus was pelleted by centrifugation at
13,000 g for 15 s. The eluate was removed and diluted 10-fold in phosphate buffer (0 .1
M, pH 6.1) containing 50 mM EDTA and 1 .0% NP-40. Aliquots of equal volume (25 Al)
were placed into microfuge tubes. Endo F (New England Nuclear, Boston, MA) was
added to a final concentration of 23 U/ml, and samples were incubated for 16 h at 37 °C.
An equal volume (25 Al) of 2X sample buffer containing 10% 2-ME was added to each
sample to quench the digestion and samples were incubated in a boiling water bath for
5 min. Samples were analyzed by SDS-PAGE and NEPHGE.
Phosphorylation. Cells were washed and incubated for 1 h at 37°C in phosphate-free
buffer (modified MEM phosphate-free Earle's salts with 25 mM Hepes (Irvine Scientific,
Santa Ana, CA) supplemented with 1 mM glutamine, nonessential amino acids, 100 tag/
ml gentamicin, and 2% heat-inactivated horse serum [dialyzed against modified MEM
phosphate-free Earle's salts]) . Cells were resuspended in phosphate-free buffer at 5 X
107 cells/ml containing 1 .25 mCi/ml [32p]orthophosphate (carrier-free ; Amersham
'Abbreviations used in this paper. CHAPS, 3[3-cholamidopropyl-dimethylammonio]-1-propane sulfo-
nate ; NEPHGE, nonequilibrium pH gradient electrophoresis ; PE, phycoerythrin .
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Corp.) and 800 U/ml rIL-2 . Cells were incubated for 3 h at 37°C, and then washed three
times in cold PBS containing 0.1 mM Na3VO4, 0.4 mM EDTA, 10 mM Na4P10,, 10 MM
NaF, and 0.1% NaN3 . Cells were solubilized in 0.5 ml 5 mM CHAPS lysis buffer (50 mM
Tris-HCI, 150 mM NaCl, 0.02% sodium azide, pH 8.0) containing 1 mM PMSF, 10 mM
iodoacetamide, and 10 mM NaF . After incubation at 4°C for 45 min, nuclei were
removed by centrifugation at 13,000 g for 3 min . Lysates were precleared twice by incu-
bation with packed formalin-fixed S . aureus (Pansorbin ; Calbiochem-Behring Corp.)
coated with rabbit anti-mouse Ig serum (Pel-Freeze Biologicals) (22) . Immunoprecipita-
tion was performed using anti-Leu-23 n Ab bound to rabbit anti-mouse Ig-coated S.
aureus, as described (22) . After immunoprecipitation, samples were transferred to fresh
microfuge tubes and antigen was eluted using sample buffer containing 2.3% SDS.
Immunoprecipitates were analyzed by two-dimensional "diagonal" gel electrophoresis
(24) . After second-dimension electrophoresis, gels were stained in 0 .1% Coomassie Blue
R-250, 50% methanol, 7.5% acetic acid for 20- min, and then incubated overnight at
room temperature in 50 mM NaH2P04;'`10% TCA solution . Gels were subsequently de-
stained twice for 20 min in 5% methanol, 7.5% acetic acid solution, and finally washed
for 20 min in distilled water containing 5% glycerol . Gels were dried and autoradio-
graphed at -70°C on Kodak XR film using intensifying screens (Cronex Lightening Plus ;
DuPont Co., Wilmington, DE) .
Results
Expression of Leu-23 on IL-2-activated Lymphocytes . Anti-Leu-23 specifically
reacted with essentially all IL-2-activated NK cells, but reacted only weakly with
a minor proportion of resting peripheral blood NK cells (Table I) . Similarly,
anti-Leu-23 was negative or reacted only weakly with most resting peripheral
blood T and B lymphocytes . However, expression of Leu-23 antigen is not
restricted to activated NK cells . As summarized in Table I, Leu-23 is also present
TABLE I
Cellular Distribution of Leu-23
Cell type
Normal peripheral blood
T lymphocytes (CD3+)
B lymphocytes (CD19+)
NK lymphocytes (CD16')
Monocytes
Granulocytes
Normal thymocytes
Normal splenocytes
Normal bone marrow
IL-2-dependent cell lines
CD8 + alloantigen-directed CTL cell
lines
CD4+ tetanus toxoid helper T clones
Thymocyte cell lines
NK cell lines
PHA-activated T lymphoblasts (3 d)
Reactivity
0-5% positive*
0-5% positive*
0-15% positive*
Weakly positive*
<5% positive
^-30% positive
^-10% positive
^-10%
4/4 positivel
5/5 positive ,
4/4 positive "
5/5 positive.
^-50% positive
Binding was assessed by direct or indirect immunofluorescence using
flow cytometric analysis .
Based on analysis of 10 normal, adult blood donors .
" Indicates that at least 50% of cells within the cell line expressed detect-
able amounts of Leu-23 antigen .
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on most IL-2-dependent CD8+ CTL cell lines,, CD4 + tetanus-toxoid-specific
helper T cell clones, IL-2-dependent thymocyte cultures, and mitogen-activated
T lymphocytes . The antigen does not simply correlate with proliferation per se,
since it could not be detected on several cultured T leukemia cell lines (HPB-
ALL, PEER, CCRF-CEM) and an EBV-transformed B lymphoblastoid cell line
(CCRF-SB) .
Biochemical analysis of the Leu-23 antigen was conducted to determine
whether the different cell types expressing the antigen would demonstrate sim-
ilar structural properties . As shown in Fig . 1 A, an essentially identical structure
was immunoprecipitated from IL-2-dependent cell lines of peripheral blood NK
cells, peripheral blood T lymphocytes, and thymocytes. Anti-Leu-23 immuno-
precipitated a disulfide-bonded 50-60-kD glycoprotein that dissociated into sub-
units of 32 kD and 28 kD after reduction . Two-dimensional "diagonal" SDS-
PAGE analysis confirmed disulfide bonding of the subunits, and the relative
mobility of the subunits below the diagonal suggested that these proteins may
form dimers of 32 + 32 kD, 32 + 28 kD, and 28 + 28 kD proteins (Fig. 1 B) .
Deglycosylation of the antigen with a predetermined optimal concentration of
Endo F enzyme revealed a single protein of 24 kD. In experiments to optimize
Endo F digestion conditions, a partially deglycosylated species was observed with
a relative mobility of 28 kD. Since Endo F cleaves both high mannose and com-
plex types of carbohydrates linked through asparagine to the peptide, the Leu-
23 antigen is apparently a protein of 24 kD with at least two sites for N-linked
glycosylation . Two-dimensional NEPHGE analysis of the intact and deglycosy-
lated Leu-23 antigen further indicated that the 32- and 28-kD subunits likely
represent the same polypeptide that differs by the addition of a single N-linked
carbohydrate (Fig. 2 B) . The deglycosylated 24-kD protein was resistant to fur-
ther digestion with N-glycanase, an enzyme that hydrolyzes asparagine-linked oli-
gosaccharides that may be resistant to Endo F treatment (not shown). The
microheterogeneity observed in the deglycosylated 24-kD protein may have
resulted from carbamylation of the protein by urea during NEPHGE analysis,
or alternatively could be due to the presence of enzyme-resistant carbohydrates
or O-linked oligosaccharides .
Induction of Leu-23 Antigen. Experiments were conducted to determine the
conditions necessary to induce expression of Leu-23 on NK cells and T lympho-
cytes . Peripheral blood lymphocytes were separated into low buoyant density
and high buoyant density fractions using Percoll gradient centrifugation . As pre-
viously reported (17), the high buoyant density cells were >95% small, resting
T lymphocytes and the low buoyant density fraction contained both NK cells and
T lymphocytes . Lymphocytes were cultured in 500 U/ml IL-2 and aliquots were
removed after 2, 6, and 18 h of culture . Cells were stained by two-color immu-
nofluorescence with phycoerythrin-(PE)-conjugated anti-Leu-23 and either
FITC-conjugated anti-Leu-11 (CD16) to identify NK cells or FITC-conjugated
anti-Leu 4 (CD3) to identify T lymphocytes . Before stimulation with IL-2, Leu-
23 was not detectable on low buoyant density (large) T cells or high buoyant
density (small) T cells, and was presently only in low amounts on a minor pro-
portion of NK cells (Fig . 3) . However, Leu-23 was detected by 6 h after IL-2
stimulation on the majority of NK cells and a subset of the T lymphocytes in the
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low buoyant density fraction . Within 18 h, essentially all IL-2-stimulated NK
cells expressed Leu-23 . By contrast, only a minor proportion of IL-2-stimulated
NK cells expressed transferrin receptors, HLA-DR or CD25 (Fig. 4) . Since all
NK cells expressed Leu-23 within 18 h after exposure to IL-2, this indicates that
FIGURE 1 . Immunoprecipitation of Leu-23 . (A) IL-2-dependent lines of NK cells, thymo-
cytes (Thy), and peripheral blood T lymphocytes were radiolabeled with 1Z5í and were deter-
gent solubilized. Lysates were immunoprecipitated using S. aureus coated with control immu-
noglobulin or anti-Leu 23 . Immune complexes were eluted in sample buffer containing 2.3%
SDS with or without 5% 2-ME. Samples were analyzed using 10% acrylamide gels . (B) An
aliquot of the anti-Leu-23 immunoprecipitate of IL-2-cultured thymocytes shown in A was
analyzed by two-dimensional "diagonal" SDS-PAGE (1st dimension, nonreducing (NR), 7 .5%
acrylamide gels ; 2nd dimension, reducing (R), 10% acrylamide gels) .
FIGURE 2.
	
Deglycosylation of Leu-23 . (A) An aliquot of the anti-Leu-23 immunoprecipitate
of IL-2-cultured thymocytes shown in Fig. I A was de-glycosylated using Endo F and analyzed
by SDS-PAGE (A) and two-dimensional NEPHGE (B) using 10% acrylamide gel. (-) No Endo
F digestion; (+) Endo F.
all NK cells are IL-2 responsive . NK cells maintained in culture with IL-2 for
72 h remained uniformly Leu-23+ (not shown) . Whereas all NK cells acquired
Leu-23, even after 72 h of culture with IL-2 only a subset of the T lymphocytes
in the low buoyant density fraction expressed this antigen (not shown) . In con-
trast to the T lymphocytes in the low buoyant density fraction, IL-2 did not
induce Leu-23 expression on a substantial proportion of the small, resting T
NK Cells Large T Cells Small T Cells
Fluorescence (4 Log)
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FIGURE 3. Kinetics of induction . Low buoyant density
and high buoyant density peripheral blood lymphocytes
were cultured in serum-free medium in the presence or
absence of 500 U/ml IL-2 . At 0, 2, 6, and 18 h, aliquots
of cells were stained with : FITC-conjugated IgG and PE-
conjugated anti-IgG control antibodies ; FITC-conju-
gated anti-CD16 (Leu 11) and PE-conjugated anti-Leu-
23 ; and FITC-conjugated anti-CD3 (Leu-4) and PE-con-
jugated anti-Leu-23 . Samples were analyzed by flow
cytometry . Electronic gates were set on low buoyant
density CD16+ cells (NK cells), low buoyant density
CD3+ cells (large T cells), and high buoyant density
CD3+ cells (small T cells) and data were reprocessed to
determine the amount of Leu-23 antigen expression on
each population . Histograms of anti-Leu-23-stained
cells are superimposed over the histograms of cells
stained with the IgGI control antibody. The control is
the histogram nearest the ordinate in each plot .
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A Leu-23
C HLA-DR . D CD25
A -IL-2 B +IL-2
Fluorescence (4 Log) Fluorescence (4 Log)
lymphocytes in the high buoyant density fraction (Fig. 3), even after 72 h of
culture (not shown) .
Induction of Leu-23 antigen by IL-2 was dose dependent (Fig . 5) . After 18 h
of culture, low levels of Leu-23 antigen were induced on NK cells at 3 U/ml IL-
2, and 100 U/ml IL-2 was sufficient for induction of the antigen on a majority
of NK cells . IL-2 was necessary and sufficient to induce expression of Leu-23
on NK cells. As shown in Fig. 6., NK cells, purified by isolating CD16+ lympho-
cytes from the low buoyant density fraction using a FACS, acquired expression
Fluorescence (4 Log) Fluorescence (4 Log)
Fluorescence (4 Log) Fluorescence (4 Log)
FIGURE 4. Activation antigens expressed on IL-2-
stimulated NK cells . Low buoyant density peripheral
blood lymphocytes were cultured in serum-free
medium in the presence or absence of 500 U/ml II:
2 . After 18 h, cells were stained with : FITC-conju-
gated IgG and PE-conjugated IgG control antibod-
ies; FITC-conjugated anti-Leu-23 (A) and PE-conju-
gated anti-CD16 (Leu-11), FITC-conjugated anti-
transferrin receptor (B) and PE-conjugated anti-
CD16 (Leu-11) ; FITC-conjugated anti-CD16 (Leu-
11) and PE-conjugated anti-HLA-DR (C) ; and FITC-
conjugated anti-CD16 (Leu-11) and PE-conjugated
anti-CD25 (IL-2-R) (D) . Cells were analyzed by flow
cytometry . An electronic gate was placed on CD16'
NK cells and data were reprocessed to determine the
amount of each activation antigen coexpressed on
NK cells . Data are presented as described in Fig. 3.
FIGURE 5. IL-2 Concentration required for induction .
Low buoyant density peripheral blood lymphocytes were
cultured in serum-free medium in the presence or
absence of the indicated concentration of IL-2 . After 18
h, cells were stained with: FITC-conjugated IgG and PE-
conjugated IgG control antibodies ; and FITC-conju-
gated anti-CDI6 (Leu-11) and PE-conjugated anti-Leu-
23 . Cells were analyzed by flow cytometry . An electronic
gate was placed on CD16+ NK cells and data were
reprocessed to determine the amount of Leu-23 antigen
coexpressed on NK cells . Data are presented as
described in Fig. 3.
FIGURE 6. Induction of Leu-23 on purified NK cells .
Low buoyant density peripheral blood lymphocytes were
stained with FITC-conjugated anti-CD16 (Leu-11) and
CD16+ NK cells were isolated to >95% purity using a
FACS . NK cells were cultured in serum-free medium in
the presence or absence of the indicated concentration
of IL-2 . After 18 h, cells were stained with : PE-conju-
gated Ig control antibody and PE-conjugated anti-Leu
23 . Cells were analyzed by flow cytometry. Data are pre-
sented as described in Fig. 3.
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of Leu-23 after 18 h of culture with IL-2 . T lymphocytes, monocytes, or other
accessory cells were not required for IL-2 to induce the expression of Leu-23
on NK cells .
Correlation ofLeu-23 Antigen and IL-2-induced Cytotoxicity . We have previously
demonstrated that NK cells can lyse NK-resistant tumor cell targets, including
autologous tumors, after activation by IL-2 (3). The kinetics and dose require-
ments for IL-2-enhanced cytotoxicity are quite similar to those required for the
induction of Leu-23 antigen (2, 3) . Thus, further studies were conducted to
determine whether IL-2 enhancement of cytotoxicity would correlate with
expression of Leu-23 . In these experiments, low buoyant density cells were cul-
tured with 100 U/ml IL-2 for 18 h in the presence or absence of neutralizing
anti-IL-2 serum. As shown in Table II, both IL-2-enhanced cytotoxicity against
a colon carcinoma cell line and induction of Leu-23 on NK cells were compar-
ably inhibited by the neutralizing antiserum. Note the quantitative relationship
between inhibition of cytotoxicity and inhibition of Leu-23 antigen induction .
These results demonstrate that both phenomena are IL-2 dependent, and pos-
sibly, coregulated events .
Experiments were performed to determine whether or not the level of Leu-
23 antigen expression would correlate with lytic activity . Low buoyant density
cells were cultured with 6 and 12 U/ml for 18 h, and were then stained with
FITC-conjugated anti-CD16 and PE anti-Leu-23. As shown in Fig. 3, low levels
of Leu-23 were induced on the CD16+ NK cell population under these condi-
tions . Although no distinct negative or positive subsets of Leu-23 were evident,
it was possible to identify CD16+ NK cells that were negative or expressed low
amounts of Leu-23 antigen and CD16+ NK cells that expressed relatively high
levels of Leu-23 antigen. Leu-23 negative (or "dim" positive) and Leu 23
TABLE II
IL-2 Induction ofLeu-23 and Cytotoxicity
Low buoyant density peripheral blood lymphocytes were cultured in serum-free medium in the pres-
ence or absence of 100 U/ml IL-2 with or without normal rabbit serum (1/100 dilution), rabbit anti-
IL-2 (1/100 dilution), or goat anti-IL-2 (1/100 dilution). Goat anti-IL-2 serum was used at a dilution
determined to completely neutralize 100 U/ml IL-2 . Rabbit anti-IL-2 was used at a concentration to
achieve 50% inhibition of 100 U/ml IL-2 . After 18 h of culture, cells were harvested and assayed for
cytotoxicity against "Cr-labeled K562 and Colo-205 tumor cell targets at an effector/target ratio of
12 :1 . Cells were also stained with FITC-conjugated IgG control antibody or FITC-conjugated anti-
Leu-23 and were analyzed by flow cytometry. Percent inhibition of Leu-23 antigen was determined
by comparison of the mean fluorescence of cells cultured with IL-2 in the presence or absence of
neutralizing antiserum.
Antiserum IL-2
K562
Cytotoxicity
Colo-205
Inhibition
of Colo-
205 lysis
Inhibition of
Leu-23 antigen
None - 43 0
None + 97 60
Normal serum + 100 65 0 0
Rabbit anti-IL-2 + 69 20 69 50
Goat anti-IL-2 + 41 0 100 96
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FIGURE 7. Cytotoxicity mediated
by NK cells expressing Leu-23 . Low
buoyant density peripheral blood
lymphocytes were cultured in serum-
free medium containing 6 U/ml IL-
2 (A) or 12 U/ml IL-2 (B) . After 18
h, cells were harvested and stained
with FITC anti-Leu-23 and PE anti-
CD16 (Leu-11) . CD16+, Leu-23 -
(or dim Leu-23) and CD16+ , Leu-
23+ cells were isolated to >95%
purity using a FACS . Reanalysis of
the sorted fractions is presented.
The histogram of FITC-conjugated
IgG control stained cells is nearest
the ordinate in each plot, whereas
the histograms of Leu-23 - or Leu-
23 dim population and Leu-23
bright positive cells are to the right
of the control histogram. Unsorted low buoyant density cells (0), CD16 +, Leu-23 - (or dim) 011),
and CD16+, Leu-23+ (0) cells were assayed for cytotoxicity against "Cr-labeled Colo-205 colon
carcinoma cell targets (x-axis, effector/target ratio ; y = axis, percent cytotoxicity) .
"bright" CD 16' NK cells were isolated using a FACS ; reanalysis of the purified
populations is presented in Fig. 7 . Using 6 U/ml IL-2 for induction, no aug-
mentation of cytotoxicity was observed against an NK-insensitive colon carci-
noma cell line, even though low levels of Leu-23 antigen could be detected on
the NK cell population (Fig . 7 A) . These results indicate that Leu-23 antigen can
be expressed before detection of cytotoxic activity . Using 12 U/ml IL-2 for
induction, cytotoxicity was mediated by NK cells that expressed both "dim" and
"bright" levels of Leu-23 antigen (Fig . 7 B) . Comparison of the cytotoxic activity
mediated at several effector/target ratios clearly indicated that NK cells express-
FIGURE 8 . Phosphorylation of Leu-23 . Low buoyant density peripheral blood lymphocytes
were cultured for 18 h with 800 U/ml IL-2 and were labeled with [32p] orthophosphate dur-
ing the last 3 h of culture . Cells were detergent solubilized and lysates were immunoprecip-
itated with control Ig (A) or anti-Leu-23 (B) . Samples were analyzed two-dimensional "diag-
onal" SDS-PAGE using 10% acrylamide gels for both dimensions (Ist dimension,
nonreducing [NR] ; 2nd dimension, reducing [R]) . After 15 h of culture with IL-2 (immedi-
ately before addition of [12p]orthophosphate), all CD16+ NK cells in the culture expressed
the Leu 23 antigen (-40% of the total cells), and ^-20% of the low buoyant density CD3+
T lymphocytes expressed Leu-23 (not shown) .
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ing higher levels of Leu-23 antigen were more lytic than the population of NK
cells lacking Leu-23 or expressing low levels of this antigen.
IL-2-induced Phosphorylation of Leu-23. Lymphocyte stimulation results in
activation of intracellular protein kinases, which in turn phosphorylate growth
factor receptors, components of the TCR complex, and certain other membrane
glycoproteins (26-31). Experiments were conducted to determine whether Leu-
23 is phosphorylated, as well as induced by IL-2 . In these experiments, low
buoyant density lymphocytes were cultured with IL-2 for 20 h and were labeled
with [12p] orthophosphate during the last 3 h of culture. Cells were detergent
solubilized, the Leu-23 glycoprotein was immunoprecipitated, and samples were
analyzed by two-dimensional "diagonal" SDS-PAGE (Fig . 8) . Disulfide-bonded
[32P]-labeled protein dimers composed of 32 and 28 kD subunits were detected,
identical in structure to the 121I-labeled membrane proteins presented in Fig. 1
B. Therefore, the Leu-23 glycoprotein is both induced and phosphorylated as a
consequence of IL-2 stimulation.
Discussion
Peripheral blood NK cells can be activated by IL-2, without requirement for
exogenous cofactors or accessory cells (1-4, 16). IL-2-induced activation results
both in cellular proliferation and enhancement of NK cytotoxic activity (3, 4) .
Within a few hours after exposure to IL-2, NK cells acquire the capacity to lyse
NK-resistant tumor cell targets, including fresh autologous tumor (1-3, 32, 33).
Using purified NK effector cells, cytotoxicity is maximal within 18 h after expo-
sure to IL-2 and requires protein synthesis, but not cell division (2, 3) . IL-2 also
induces the expression of certain activation antigens on the plasma membrane
of NK cells; however, most of these antigens are not detectable until substan-
tially later than detection of IL-2-enhanced cytotoxicity (1, 2, 4, 16). In the pres-
ent study, we have demonstrated that the Leu-23 antigen is detectable on the
surface of NK cells with a few hours after exposure to IL-2 . Previously, it has
been uncertain whether all NK cells or only a subset are responsive to IL-2 .
Since within 18 h after exposure to IL-2, essentially all NK cells express Leu-
23, these findings indicate that all peripheral blood NK cells are responsive to
stimulation by IL-2 . The kinetics of Leu-23 antigen induction closely parallel the
acquisition of cytolytic activity . Both expression of Leu-23 antigen and enhanced
NK cell-mediated cytotoxicity can be induced directly by exposure to IL-2, with-
out requirement for additional activation signals. Moreover, both events were
neutralized by anti-IL-2 antiserum to a comparable extent. These results suggest
that the two events may be coregulated.
The ability of IL-2 to induce Leu-23 antigen on a subset of low buoyant den-
sity T lymphocytes, but not a substantial proportion of small, resting T lympho-
cytes, suggests that this subset of T lymphocytes may be "primed" in vivo,
requiring only IL-2 for activation . Recently, London et al . (4) have reported that
a minor subset of low buoyant density T lymphocytes in peripheral blood enter
the cell cycle after exposure to IL-2 . It should be noted that we have observed
expression of Leu-23 antigen on a small subpopulation of circulating peripheral
blood T and NK lymphocytes in some normal individuals . Whether these cells
represent in vivo activated lymphocytes will be examined in further studies.
158 2
	
INTERLEUKIN 2-INDUCED ACTIVATION ANTIGEN
It is possible that the Leu-23 glycoprotein is involved in the IL-2 activation of
NK and T lymphocytes. However, we have been unable to directly demonstrate
involvement of the Leu-23 antigen with cell function . Anti-Leu-23 mAb did not
inhibit IL-2-induced NK cell-mediated cytotoxicity or IL-2-induced proliferation
of NK or T lymphocytes (unpublished observations). It is unlikely that the Leu-
23 glycoprotein is involved directly with the cytolytic process, since the antigen
is also present on noncytotoxic lymphocytes (e .g., CD4+ tetanus-toxoid-specific
T cell clones, mitogen-activated T lymphoblasts, and normal thymocytes).
Expression of Leu-23 on lymphocytes with diverse immune functions suggests
that this glycoprotein may be involved in more general processes involved with
cellular activation .
Structural features of the antigen are consistent with the possibility that Leu-
23 is a membrane receptor for growth or differentiation factors. Leu-23 is a
disulfide-linked homodimer composed of 24-kD subunits with at least two N-
linked carbohydrates. Of particular interest was the observation that the glyco-
protein is both induced and phosphorylated via an IL-2-dependent process.
Many growth factor receptors, including somatomedin C, epidermal growth fac-
tor receptor, insulin receptor, and IL-2, are phosphorylated subsequent to cel-
lular activation (26-29) . The present studies indicated that for NK cells and a
subset of low buoyant density T cells, IL-2 is the only exogenous factor neces-
sary to induce expression of Leu-23 . Further studies will be necessary to eluci-
date the intracellular events that occur subsequent to IL-2 binding and result in
the induction and phosphorylation of Leu-23 .
The EA-1 (31) and MLR3 (34) activation antigens have structural properties
and a cellular distribution similar to Leu-23 . Whether EA-1, MLR3, and Leu-
23 are the same antigen, distinct epitopes on the same antigen or different gly-
coproteins will require comparative binding and biochemical analysis . Hara et
al . (31) previously demonstrated that the EA-1 antigen is rapidly induced on T
lymphocytes after activation by mitogens or antigens and that the glycoprotein
is phosphorylated after stimulation with phorbol ester; however, in these exper-
iments the role of IL-2 in the process was not investigated . Similarly, expression
of MLR-3 is rapidly induced by mitogen activation of T lymphocytes (34) . Cosu-
lich et al . (34) have reported that mAb against MLR3 inhibits IL-1-dependent
stimulation of resting T cells using anti-CD3 . Although we have not determined
the functional effect of anti-Leu-23 mAb on IL-1-dependent T cell activation,
IL-1 did not affect expression of Leu-23 antigen on NK cells (unpublished
observation) .
In conclusion, the Leu-23 antigen is rapidly induced on peripheral blood NK
cells and a unique subset of T lymphocytes after exposure to IL-2, without the
requirement for exogenous cofactors or accessory cells. The kinetics of IL-2-
induced expression of Leu-23 on NK cells closely paralleled the acquisition of
cytotoxic function against solid tumor cell targets, thereby providing a useful
marker of NK cell activation . The rapid induction and phosphorylation of this
glycoprotein suggest that the structure may be involved in IL-2-dependent acti-
vation mechanisms . Further studies directed at defining the molecular proper-
ties of this membrane antigen may provide valuable insight into function of this
glycoprotein .
Summary
IL-2 potentiates both growth and cytotoxic function of T lymphocytes and NK
cells . Resting peripheral blood NK cells can respond directly to rIL-2, without
requirement for accessory cells or cofactors, and enhanced cytotoxicity can be
measured within a few hours after exposure to this lymphokine . In this study,
we describe an activation antigen, Leu-23, that is rapidly induced and phospho-
rylated after IL-2 stimulation of NK cells and a subset of low buoyant density T
lymphocytes . Previously, it has been uncertain whether all NK cells or only a
subset are responsive to IL-2. Since within 18 h after exposure to IL-2, essen-
tially all NK cells express Leu-23, these findings indicate that all peripheral
blood NK cells are responsive to stimulation by IL-2. The Leu-23 antigen is a
disulfide-bonded homodimer, composed of 24-kD protein subunits with two N-
linked oligosaccharides . Appearance of this glycoprotein on NK cells is IL-2
dependent and closely parallels IL-2-induced cytotoxicity against NK-resistant
solid tumor cell targets .
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